Area of research
Molecular Biology · Cell Biology
Research interest
Research interests include Melanoma and MAPK Pathways, melanin and skin pigmentation, Cutaneous Melanoma Detection and Management, and Cancer Immunotherapy and Biomarkers.
FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma
Abstract 153: High-resolution profiling of the tumor microenvironment with spatial ecotypes
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma
Unannotated microprotein EMBOW regulates the interactome and chromatin and mitotic functions of WDR5
Retrospective cell lineage reconstruction in humans by using short tandem repeats
Retrospective cell lineage reconstruction in Humans using short tandem repeats
Germline MC1R status influences somatic mutation burden in melanoma
AMPK promotes tolerance to Ras pathway inhibition by activating autophagy
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
Identification of <scp>PLX</scp>4032‐resistance mechanisms and implications for novel <scp>RAF</scp> inhibitors
Clonal growth of human melanocytes using cell‐free extracellular matrix
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Preexisting <i>MEK1</i> Exon 3 Mutations in <i>V600E/K</i> <i>BRAF</i> Melanomas Do Not Confer Resistance to BRAF Inhibitors
Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate